The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Diffuse large B-cell lymphoma – an aggressive form of non-hodgkin lymphoma Diffuse large B-cell lymphoma is a cancer of the B cells in the blood and globally represents about 30—58% of cases ...

ALK Tyrosine Kinase Inhibitors Induced Weight Gain: More Refined Definition of Weight Gain, Glucagon-Like Peptide-1 Agonist Treatment, and Therapeutic Drug Monitoring of ALK+ Non–Small Cell Lung ...

Hoffmann-La Roche Ltd (Roche) has a rich history of antibody therapies to treat cancers (malignancies) that affect B cells (a type of white blood ... lymphoma subtype, diffuse large B-cell ...

A phase 1 clinical trial has found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer ... manufacturing of a large number of doses ...